Acenxion Biosystems

About:

Acenxion Biosystems is a privately funded company developing automated medical diagnostic systems for precision medicine.

Website: https://www.acenxionbiosystems.com

Top Investors: National Institute of Allergy and Infectious Diseases, Centennial Investors

Description:

Acenxion Biosystems is a privately funded medical device company that is developing rapid, gold standard, automated systems for phenotypic antimicrobial susceptibility testing (AST) and bacterial detection in blood cultures (Sepsis). Seamlessly fitting into current clinical workflows, Acenxion’s scalable fAST system(TM) reduces the time required for phenotypic testing to just 4-6 hours (versus 2 or more days), allowing clinicians rapid use of targeted precision treatment. Acenxion’s technology improves patient outcomes, reduces healthcare costs, and reduces the spread of antibiotic resistance, extending the useful life of antibiotics (Antibiotic Stewardship).